Good extract. The next announcement should be the final results. Whilst FDA approval will likely be next year (which really isn't a long time to wait given what that means and the opportunities presented to Spontan) what we could see in the next 6 months (per the extract) is one or more partnership/licensing agreements. That will take the share price to the next level.
Ann: SPONTAN achieves positive clinical study results, page-104
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
79.0¢ |
Change
-0.020(2.47%) |
Mkt cap ! $55.62M | |||
| Open | High | Low | Value | Volume |
| 84.5¢ | 85.0¢ | 79.0¢ | $91.79K | 111.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3758 | 79.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 82.0¢ | 6000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| LTP (ASX) Chart |